About this trial
The main purpose of this study is to evaluate Fetal Medicine Foundation's pre-eclampsia risk calculator using maternal characteristics, first trimester serum placental growth factor (PlGF) and mean arterial pressure (MAP) in a Finnish general population.
Condition or disease: pre-eclampsia, intrauterine growth restriction, polycystic ovary syndrome
Eligibility criteria
Qualifiers
Pregnant (first trimester)
Understands Finnish
≥18 years
Signed informed consent
Disqualifiers
Multiple pregnancy
Miscarriage/termination of the index pregnancy
No first trimester blood sampling
Participates in PEPPI-study (criteria above)
Trial design
Treatments tested in this trial
- Pre-eclampsia screening program
Treatment groups
6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Oulu University Hospital
Lead sponsor
PerkinElmer, Inc.
Collaborator
Roche Diagnostics GmbH
Collaborator
Academy of Finland
Collaborator
Sigrid Jusélius Foundation
Collaborator
Finnish Medical Foundation
Collaborator
University of Oulu
Collaborator